Quarterly report pursuant to Section 13 or 15(d)

Marketable Securities

v3.24.1.1.u2
Marketable Securities
3 Months Ended
Apr. 30, 2024
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities Marketable Securities
The following is a summary of available-for-sale marketable securities, excluding those securities classified within cash and cash equivalents on the condensed consolidated balance sheets:
April 30, 2024
(in thousands) Amortized Cost Unrealized Gains Unrealized Losses Fair value
Corporate bonds $ 95,301  $ 14  $ (72) $ 95,243 
Municipal bonds 995  —  (1) 994 
U.S. government and agency securities 158,542  —  (254) 158,288 
Certificates of deposit 64,129  18  (35) 64,112 
Commercial paper 164,739  19  (131) 164,627 
Marketable securities $ 483,706  $ 51  $ (493) $ 483,264 
January 31, 2024
(in thousands) Amortized Cost Unrealized Gains Unrealized Losses Fair value
Corporate bonds $ 98,642  $ 71  $ (10) $ 98,703 
Municipal bonds 982  —  985 
U.S. government and agency securities 185,464  140  (33) 185,571 
Certificates of deposit 46,496  48  (1) 46,543 
Commercial paper 166,595  155  (21) 166,729 
Marketable securities $ 498,179  $ 417  $ (65) $ 498,531 
As of April 30, 2024 and January 31, 2024, the maturities of available-for-sale marketable securities did not exceed 12 months. Interest income from cash and cash equivalents and marketable securities was $8.3 million and $6.0 million for the three months ended April 30, 2024 and 2023, respectively.
There were 137 and 64 debt securities in an unrealized loss position as of April 30, 2024 and January 31, 2024, respectively. The estimated fair value of these debt securities, for which an allowance for credit losses has not been recorded, was $357.6 million and $178.7 million as of April 30, 2024 and January 31, 2024, respectively. There were no expected credit losses recorded against the Company’s investment securities as of April 30, 2024 and January 31, 2024.
Unrealized losses on the Company’s debt securities are not considered to be credit-related based upon an analysis that considered the extent to which the fair value is less than the amortized basis of a security, adverse conditions specifically related to the security, changes to credit rating of the instrument subsequent to Company purchase, and the strength of the underlying collateral, if any.
Refer to Note 5, Fair Value Measurements, for information about the fair value of the Company’s fair value hierarchy for short-term marketable securities.